Variolin derivatives as anti-cancer agents

Details Variolin derivatives as anti-cancer agents Variolin derivatives as anti-cancer agents

2008-01-22

2008-01-22

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S250000

Reexamination Certificate

active

10332562

ABSTRACT:
The invention provides variolin derivatives of formula (I), wherein: R1and R2are each independently selected from the group consisting of H, OH, OR, SH, SR, SOR, SO2R, NO2, NH2, NHR, N(R)2, NHCOR, N(COR)2, NHSO2R, CN, halogen, C(═O)H, C(═O)R, CO2H, CO2R, C1-C12alkyl, C1-C12haloalkyl, C2-C12alkenyl, C2-C12alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted aralkyl and substituted or unsubstituted heteroaromatic; and R3is selected from the group consisting of H, OH and OMe; wherein the or each group R is independently selected from the group consisting of OH, C1-C12alkyl, C1-C12haloalkyl, C2-C12alkenyl, C2-C12alkynyl, substituted or unsubstituted aryl, substituted unsubstituted aralkyl, substituted or unsubstituted arylalkenyl and substituted or unsubstituted heteroaromatic, and wherein the group R1, R2or R3is a group of formula N(R)2or N(COR)2, each of the R groups may be the same or different, or the two R groups, together with the nitrogen atom to which they are attached, may form a 5-14 membered heterocyclic ring. These compounds display activity against a range of mammalian cancer cell lines. New synthetic routes to new and known variolin compounds, together with novel intermediates, are also disclosed. New antitumour activity of known variolin compounds is also described.

REFERENCES:
patent: 2004/0058939 (2004-03-01), Alvarez et al.
patent: WO 02/12240 (2002-02-01), None
patent: WO 03/006457 (2003-01-01), None
Alvarez, M. et al., “Synthesis of deoxyvariolin B”,Tetrahedron Letters,42(2), pp. 315-317 (2001).
Alvarez, Mercedes et al., “Synthesis of 1, 2-dihydropyrrolo[1,2-c]pyrimidin-1-ones”,J. Chem. Soc. Perkins Trans. I,pp. 249-255 (1999).
Alvarez, Mercedes et al., “Synthesis of 3-Aryl- and 3-Heteroaryl-7-azaindoles”,Synthesis,pp. 615-620 (1999).
Anderson,R.J. et al., “Studies toward the total synthesis of the variolins: rapid entry to the core structure”,Tetrahedron Lett.,vol. 42(2), pp. 311-313 (2001).
Capuano, Lilly et al., “(Heterocyclizations, XIII) New Polycyclic Pyrimidines-with Bridge-Head Nitrogen”,Chem. Ber.,107, pp. 929-936 (1974).
Desarbre, Eric et al., “Synthesis of 2-Substituted-1H-Pyrrolo[2,3-b] Pyridines: Preparation of 7-Azaolivacine Analogue and 7-Azaindolopyridopyrimidine Derivatives”,Tetrahedron,53(10), pp. 3637-3648 (1997).
Erba et al., “Cell cycle phase perturbation and apoptosis induced by Variolin B, a novel antitumor agent of marine origin”,Proc. Am. Assoc. Can. Res. Annual Meeting,vol. 27, #198 pp. 28-29 (1996).
Fresneda, Pilar M. et al., “Synthetic studies towards the 2-aminopyrimidine alkaloids variolins and meridianins from marine origin”,Tetrahedon Lett.,41(24), pp. 4777-4780 (2000).
Girgis, Nabih S. et al., “The Synthesis of 5-Azaindoles by Substitution-Rearrangement of 7-Azaindoles upon Treatment with Certain Primary Amines”,J. Heterocyclic Chem.,vol. 26, No. 2, pp. 317-325 (1989).
Katritzky, Alan R. et al,Comprehensive Heterocyclic Chemistry, Pergamon Press, Oxford,vol. 3, p. 111 (1984).
Katritzky, Alan R. et al., “Activation of the 2-Alkyl Group of a 2-Alkylindole toward Proton Loss and Subsequent Electrophilic Substitution”,J. Am. Chem. Soc.,vol. 108, No. 21, pp. 6808-6809 (1986).
Lorenz et al. “A New Indole Synthesis1”,J. Org. Chem.,vol. 30, pp. 2531-2533 (1965).
Majeed, Amera J. et al., “Stannylation Reactions and Cross-Couplings in Pyrimidines”,Tetrahedron,vol. 45, No. 4, pp. 993-1006 (1989).
Mendiola, Javier et al., “Reaction of 2-Bromomethylazoles and TosMIC: A Domino Process to Azolopyrimidines. Synthesis of Core Tricycle of the Variolins Alkaloids”,Organic Letters,vol. 2, No. 21, pp. 3253-3256 (2000).
Perry,Nigel B. et al., “Alkaloids from the Antarctic spongeKirkpatrickia varialosa.Part 1: Variolin B, a new antitumor and antiviral compound”Tetrahedron,50(13), pp. 3987-3992 (1994).
Sawayama, Tadahiro et al., “Displacement Reactions of 2-Alkylsulfonyl-4-Chloropyrimidine Derivatives with Nucleophiles”,Heterocycles,vol. 8, pp. 299-305 (1977).
Perry, Nigel B. et al., “Alkaloids from the Antarctic SpongeKirkpatrickia varialosa.Part 2: Variolin A and N(3′)-methyl tetrahydrovariolin B”,Tetrahedron,vol. 50, No. 13, pp. 3993-4000 (1994).
Vorbrüggen et al., “Sysntheses of Nucleosides—Amination of Heterocycles—A New Simple Synthesis of Cytidines”,Liebigs Annalen Der Chemie,pp. 988-1002 (1975).
Calabresi et al., “Chemotherapy of Neoplastic Diseases”, Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw-Hill, 1996, pp. 1225-1229.
Charya et al., “Wynthesis and Evaluation of Sulphonylhydrazones of Phthalimido Acetaldehyde as Anticancer Agents”, J. Indian Chem Soc., vol. 75, pp. 46-48 (1998).

Affiliated with

Also associated with

Rating

Variolin derivatives as anti-cancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Variolin derivatives as anti-cancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Variolin derivatives as anti-cancer agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3914763